| Lindsay Guthrie, CPNP-AC | |
|
601 Childrens Ln, Norfolk, VA 23507-1971 | |
| (503) 729-5303 | |
| Not Available |
| Full Name | Lindsay Guthrie |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Pediatrics, Critical Care |
| Location | 601 Childrens Ln, Norfolk, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891493607 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0214X | Pediatrics - Pediatric Pulmonology | 00024185842 (Virginia) | Secondary |
| 363LP0222X | Nurse Practitioner - Pediatrics, Critical Care | 0024185842 (Virginia) | Primary |
| Entity Name | Childrens Specialty Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255354130 PECOS PAC ID: 5890788764 Enrollment ID: O20040406001195 |
News Archive
Yale Cancer Center scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced it raised $25 million in Series B financing. Led by BVCF, a private equity and growth fund specializing in the life sciences industry, the round also includes existing investors Morningside Group and Devon Park Bioventures.
Research revealed during "Get Smart Week" shows that California joined Alaska, Hawaii, Oregon and Washington as the five states with the lowest antibiotic use in the nation in 2010.
This suggests a cocktail of antibodies will work better at neutralizing the virus than a single antibody alone. In a study published in the bioRxiv* preprint server, researchers report the structure of binding complexes of the different classes of antibodies to the spike RBD using computational modeling, which may also help explain how the virus generates escape mutations.
Results from the first national study of children with cancer who test positive from COVID-19 has found that these patients do not appear to be at any increased risk of severe COVID-19 infection compared to healthy children.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lindsay Guthrie, CPNP-AC 7415 Yorktown Dr, Norfolk, VA 23505-3511 Ph: (503) 729-5303 | Lindsay Guthrie, CPNP-AC 601 Childrens Ln, Norfolk, VA 23507-1971 Ph: (503) 729-5303 |
News Archive
Yale Cancer Center scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced it raised $25 million in Series B financing. Led by BVCF, a private equity and growth fund specializing in the life sciences industry, the round also includes existing investors Morningside Group and Devon Park Bioventures.
Research revealed during "Get Smart Week" shows that California joined Alaska, Hawaii, Oregon and Washington as the five states with the lowest antibiotic use in the nation in 2010.
This suggests a cocktail of antibodies will work better at neutralizing the virus than a single antibody alone. In a study published in the bioRxiv* preprint server, researchers report the structure of binding complexes of the different classes of antibodies to the spike RBD using computational modeling, which may also help explain how the virus generates escape mutations.
Results from the first national study of children with cancer who test positive from COVID-19 has found that these patients do not appear to be at any increased risk of severe COVID-19 infection compared to healthy children.
› Verified 1 days ago